Acknowledgements

Our Collaborators

We would like to acknowledge the collaborators from numerous institutions who have helped us!

Cornell University
- Aimee Colbath, VMD, PhD, DACVS-LA
Drexel University
- Lin Han, PhD
Hospital for Special Surgery
- Scott Rodeo, MD
Northwestern University
- Richard Miller, PhD
Rush University
- Anne-Marie Malfait, MD, PhD
- Rachel E Miller, PhD
Scripps Research
- Martin Lotz, MD
Sorbonne Université
- Francis Berenbaum, MD, PhD
The Rockefeller University
- Dana Orange, MD, MS
University Health Network, Toronto
- Mohit Kapoor, PhD
University of Aberdeen
- Cosimo De Bari, MD, PhD FRCP
University of Illinois - Chicago
- Lola Eniola-Adefeso, PhD, FAHA, FAIMBE, FBMES, FCRS, NAI

University of Michigan
- Kurt Hankenson, DVM, PhD
- Rhima Coleman, PhD
- Andrea Alford, PhD
- Yadav Wagley, PhD
- John Varga, MD
- David Fox, MD
- Eliza Tsou, PhD
- Annemarie Lang, PhD
University of North Carolina - Chapel Hill
- Brian Diekman, PhD
University of Pennsylvania
- Carla Scanzello, MD, PhD
- Robert Mauck, PhD
University of Texas Southwestern
- Robert Tower, PhD
- Benjamin Levi, MD
University of Washington - St. Louis
- Alex Knights, PhD
Vanderbilt University
- Craig Duvall, PhD
Western University
- C Thomas Appleton, MD, PhD

Our Grants

We want to thank our generous donors because without them, we would not have been able to get to where we are today!

R01 AR080035, NAIMS. “Sustained Biomaterial-mediated Inhibition of R-spondin 2 to Target Pathological Wnt Signaling in Post-Traumatic Osteoarthritis.” Tristan Maerz (PI), 9/2022 - 8/2027
UC2 AR082186, NIAMS. “Mapping the joint-nerve interactome of the knee.” Anne-Marie Malfait (PI), Richard Miller (MPI), Martin Lotz (MPI), Tristan Maerz (Site-PI, Co-I), Rachel Miller (Site-PI, Co-I), Dana Orange (Site-PI, Co-I), 9/2022 - 8/2027
R21 AR076487, NIAMS. “Targeting Pathological Angiogenesis after Join Injury”, Tristan Maerz (PI), Andrea Alford (MPI), 8/2021 - 8/2023
R21 AR080502, NIAMS. “Bioerodible corticosteroid microparticle-drug as an intra-articular drug delivery system for osteoarthritis therapy.” Lola Eniola-Adefeso (PI), Tristan Maerz (MPI), 9/2022 - 8/2024
R21 AR082016, NAIMS. “Autonomous RUNX2 suppression in genetically modified stem cell-derived chondrocytes as a disease-modifying therapeutic for PTOA.” Rhima Coleman (PI), Tristan Maerz (MPI), 3/2023 - 2/2025
Catalyst Award, Dr. Ralph and Marian Falk Medical Trust, “Targeting Pathological Rspo2-mediated Wnt/β-Catenin Signaling as a Novel Treatment for Osteoarthritis.” Tristan Maerz (PI), 2/2021 - 2/2023
Focused Program Award, GRANT13696744, Department of Defense Congressionally Directed Medical Research Programs (CDMRP). “Pivotal and Diverse Roles for Matricellular Proteins in Musculoskeletal Disorders.” Kurt Hankenson (PI), Tristan Maerz (Project PI), Andrea Alford (Project PI), Craig Duvall (Project PI), Ben Levi (Project PI), Robert Tower (Project PI)